Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Skin Infections and Their Management

Common Skin Infections

  • The most common skin infections in clinical practice are impetigo, cellulitis, erysipelas, and folliculitis, with Staphylococcus aureus and Streptococcus pyogenes being the predominant causative pathogens, according to the Infectious Diseases Society of America 1, 2
  • Impetigo is caused by S. aureus and/or S. pyogenes, and presents as honey-colored crusted lesions or thin-roofed vesicopustules, as recommended by the American Academy of Pediatrics 2, 3
  • Treatment for localized impetigo includes topical mupirocin or retapamulin twice daily for 5 days, with a strong recommendation from the American Academy of Dermatology 3, 4
  • For widespread impetigo, oral antibiotics active against both S. aureus and S. pyogenes for 7 days are recommended, according to the Centers for Disease Control and Prevention 2, 3
  • Cellulitis is an infection of dermis and subcutaneous tissue with poorly demarcated borders, usually caused by streptococci or staphylococci, as stated by the Infectious Diseases Society of America 2, 5
  • Erysipelas is a superficial form of cellulitis with well-demarcated borders, typically caused by streptococci, and penicillin is the treatment of choice, as recommended by the American College of Physicians 2, 6
  • For cellulitis, penicillinase-resistant semisynthetic penicillin or first-generation cephalosporin is recommended, with options including penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin, according to the American Academy of Family Physicians 1, 5
  • A 5-day course of antibiotics is as effective as a 10-day course if clinical improvement occurs by day 5, as stated by the Infectious Diseases Society of America 1, 5
  • MRSA coverage is usually unnecessary for typical cellulitis but may be prudent in cases with purulent drainage, penetrating trauma, or concurrent MRSA infection elsewhere, as recommended by the Centers for Disease Control and Prevention 1, 5
  • Incision and drainage is the primary treatment for furuncles and carbuncles, with antibiotics if extensive surrounding cellulitis or systemic symptoms, according to the American College of Surgeons 7, 8

Antibiotic Selection

  • For streptococcal infections, penicillin is the first-line antibiotic, as recommended by the American Heart Association 2, 6
  • For staphylococcal or mixed infections, beta-lactam antibiotics are recommended, including dicloxacillin, cephalexin, amoxicillin-clavulanate, according to the Infectious Diseases Society of America 1, 5
  • For penicillin-allergic patients, clindamycin, macrolides, or SMX-TMP are recommended, as stated by the American Academy of Allergy, Asthma, and Immunology 2

Special Considerations

  • Uncomplicated cellulitis can be treated for 5 days if clinical improvement occurs, as recommended by the Infectious Diseases Society of America 1
  • More severe infections typically require 7-14 days of treatment, according to the Centers for Disease Control and Prevention 1
  • Elevation of the affected area and treatment of predisposing conditions can help promote recovery, as stated by the American College of Physicians 1
  • Systemic corticosteroids may be considered in nondiabetic adults with cellulitis, with a weak recommendation from the American College of Rheumatology 1
  • Annual recurrence rates of 8-20% for cellulitis, especially in the legs, can be decreased by addressing risk factors such as edema, venous insufficiency, prior trauma, tinea pedis, obesity, and tobacco use, as recommended by the American Heart Association 1
  • Blood cultures are unnecessary for typical cellulitis but should be obtained for patients with malignancy, severe systemic features, or unusual predisposing factors, according to the Infectious Diseases Society of America 1, 5

Amoxicillin-Clavulanate for Skin and Soft Tissue Infections

Introduction to Amoxicillin-Clavulanate Use

  • The Infectious Diseases Society of America (IDSA) recommends amoxicillin-clavulanate for treating impetigo in both pediatric and adult patients, with a standard oral dosing of 875/125 mg twice daily for adults, or 25 mg/kg/day of the amoxicillin component in 2 divided doses for children, providing coverage against Staphylococcus aureus and Streptococcus pyogenes 9, 10

Specific Indications

  • Amoxicillin-clavulanate is the first-line oral agent for both animal and human bite wounds, with 875/125 mg twice daily orally recommended, providing coverage against Pasteurella multocida, streptococci, staphylococci, and anaerobes 11, 12
  • For human bites, the same dosing applies, covering Eikenella corrodens, streptococci, S. aureus, and multiple anaerobes (Fusobacterium, Prevotella, Porphyromonas) 11, 13
  • Amoxicillin-clavulanate is listed among recommended oral options for mild diabetic foot infections, providing broad coverage for the mixed aerobic and anaerobic flora commonly found in diabetic wounds 9

Limitations and Precautions

  • Amoxicillin-clavulanate misses MRSA coverage, so if MRSA is suspected or documented, alternative agents such as vancomycin, linezolid, daptomycin, ceftaroline, clindamycin (if susceptible), doxycycline, or trimethoprim-sulfamethoxazole are needed 11, 10, 9
  • Do not use amoxicillin-clavulanate for purulent skin infections where MRSA is likely or confirmed 11, 10

Dosing and Administration

  • Adults: 875/125 mg orally twice daily 11, 10
  • Children: 25-50 mg/kg/day of amoxicillin component in 2-4 divided doses 10
  • Bite wounds: 3-5 days for prophylaxis in high-risk wounds 11, 12

REFERENCES